Corrigendum to 'Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics' [Genes & Diseases 10 (2023) 1367-1401]
- PMID: 38572324
- PMCID: PMC10990713
- DOI: 10.1016/j.gendis.2024.101211
Corrigendum to 'Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics' [Genes & Diseases 10 (2023) 1367-1401]
Abstract
[This corrects the article DOI: 10.1016/j.gendis.2022.02.007.].
© 2024 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.
Erratum for
-
Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics.Genes Dis. 2022 Mar 18;10(4):1367-1401. doi: 10.1016/j.gendis.2022.02.007. eCollection 2023 Jul. Genes Dis. 2022. PMID: 37397557 Free PMC article. Review.
Publication types
LinkOut - more resources
Full Text Sources